[Therapy of space-occupying intracranial processes (brain edema, brain tumor) and low cerebrospinal fluid pressure].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D001929:Brain Edema / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D001932:Brain Neoplasms / Q000150:complications / Q000601:surgery*; D002557:Cerebrospinal Fluid Shunts; D004232:Diuretics / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006601:Hexoses / Q000627:therapeutic use; D006801:Humans; D007427:Intracranial Pressure; D009539:Nicotinic Acids / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D012503:Saponins / Q000627:therapeutic use; D013012:Sorbitol / Q000627:therapeutic use; D013129:Spinal Puncture / Q000009:adverse effects; D014508:Urea / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D004232:Diuretics; D006601:Hexoses; D009539:Nicotinic Acids; D012503:Saponins; D013012:Sorbitol; D014508:Urea; D010208:Papaverine; D005947:Glucose
Die Therapie raumfordernder intrakranieller Prozesse (Hirnödem, Hirntumor) und des Liquorunterdrucks.